{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:56:14Z","timestamp":1791568574717,"version":"4.3.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013806","name":"Shenyang Pharmaceutical University","doi-asserted-by":"publisher","award":["202410163050"],"award-info":[{"award-number":["202410163050"]}],"id":[{"id":"10.13039\/501100013806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22177079"],"award-info":[{"award-number":["22177079"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22477085"],"award-info":[{"award-number":["22477085"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bioorg.2025.109083","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:36:33Z","timestamp":1760099793000},"page":"109083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis, and activity evaluation of selective CDK9 inhibitors containing indazole fragments"],"prefix":"10.1016","volume":"166","author":[{"given":"Xizhe","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houlin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiayu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huali","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2025.109083_bb0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/ijms18010197","article-title":"Colorectal carcinoma: a general overview and future perspectives in colorectal cancer","volume":"18","author":"M\u00e1rmol","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109083_bb0010","article-title":"Screening and prevention of colorectal cancer","volume":"374","author":"Kanth","year":"2021","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.bioorg.2025.109083_bb0015","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3390\/cancers13092025","article-title":"A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis","volume":"13","author":"Sawicki","year":"2021","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109083_bb0020","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.bioorg.2025.109083_bb0025","doi-asserted-by":"crossref","DOI":"10.1177\/10732748211056692","article-title":"Risk factors for the diagnosis of colorectal cancer","volume":"29","author":"Lewandowska","year":"2022","journal-title":"Cancer Control"},{"key":"10.1016\/j.bioorg.2025.109083_bb0030","article-title":"Expression of cyclin-dependent kinases and their clinical significance with immune infiltrates could predict prognosis in colorectal cancer","volume":"29","author":"Fadaka","year":"2021","journal-title":"Biotechnol. Rep."},{"key":"10.1016\/j.bioorg.2025.109083_bb0035","article-title":"Compensatory induction of MYC expression by sustained CDK9 inhibition via a BRD4-dependent mechanism","volume":"4","author":"Lu","year":"2015","journal-title":"ELIFE"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109083_bb0040","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tcb.2021.01.010","article-title":"New insights into CDK regulators: novel opportunities for cancer therapy","volume":"31","author":"Bury","year":"2021","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bioorg.2025.109083_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.921710","article-title":"Comprehensive analysis of role of cyclin-dependent kinases family members in colorectal cancer","volume":"12","author":"Guan","year":"2022","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109083_bb0050","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.2174\/1874467215666220124125809","article-title":"Promising anticancer activity of multitarget cyclin dependent kinase inhibitors against human colorectal carcinoma cells","volume":"15","author":"Manohar","year":"2022","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109083_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.757120","article-title":"Cyclin-dependent kinase inhibitors and their therapeutic potential in colorectal cancer treatment","volume":"12","author":"Thoma","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109083_bb0060","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/cancers17050774","article-title":"Cyclin-dependent kinase inhibition in prostate Cancer: past, present, and future","volume":"17","author":"Siskin","year":"2025","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109083_bb0065","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/biomedicines11030928","article-title":"Evaluation of CDK9 inhibition by dinaciclib in combination with apoptosis modulating izTRAIL for the treatment of colorectal cancer","volume":"11","author":"Shen","year":"2023","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.bioorg.2025.109083_bb0070","doi-asserted-by":"crossref","first-page":"10035","DOI":"10.1021\/acs.jmedchem.4c00233","article-title":"Discovery of orally bioavailable and potent CDK9 inhibitors for targeting transcription regulation in triple-negative breast Cancer","volume":"67","author":"Wang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2025.109083_bb0075","doi-asserted-by":"crossref","first-page":"15189","DOI":"10.1021\/acs.jmedchem.1c01249","article-title":"Discovery of a series of 7-azaindoles as potent and highly selective CDK9 inhibitors for transient target engagement","volume":"64","author":"Barlaam","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109083_bb0080","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ejmech.2018.09.025","article-title":"Discovery of 4-(((4-(5-chloro-2-(((1s, 4s)-4-((2-methoxyethyl) amino) cyclohexyl) amino) pyridin-4-yl) thiazol-2-yl) amino) methyl) tetrahydro-2H-pyran-4-carbonitrile (JSH-150) as a novel highly selective and potent CDK9 kinase inhibitor","volume":"158","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109083_bb0085","doi-asserted-by":"crossref","first-page":"5990","DOI":"10.1096\/fj.201801789RR","article-title":"Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancer","volume":"33","author":"Wang","year":"2019","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109083_bb0090","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.cell.2018.09.051","article-title":"Targeting CDK9 reactivates epigenetically silenced genes in cancer","volume":"175","author":"Zhang","year":"2018","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109083_bb0095","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1021\/acs.jmedchem.3c02329","article-title":"Identification of a novel selective CDK9 inhibitor for the treatment of CRC: design, synthesis, and biological activity evaluation","volume":"67","author":"Zhong","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109083_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.poly.2022.116124","article-title":"A retrospective-prospective review of Suzuki\u2013Miyaura reaction: From cross-coupling reaction to pharmaceutical industry applications","volume":"227","author":"Farhang","year":"2022","journal-title":"Polyhedron"},{"issue":"8","key":"10.1016\/j.bioorg.2025.109083_bb0105","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1021\/acs.oprd.9b00161","article-title":"The 25th Anniversary of the Buchwald\u2013Hartwig Amination: Development, Applications, and Outlook","volume":"23","author":"Forero-Cort\u00e9s","year":"2019","journal-title":"Org. Process. Res. Dev."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109083_bb0110","doi-asserted-by":"crossref","first-page":"11586","DOI":"10.1021\/acs.jmedchem.5c00472","article-title":"Discovery and administration optimization of novel selective CDK9 inhibitor, 1-7a-B1, for improved pharmacokinetics and antitumor efficacy in vivo","volume":"68","author":"Xu","year":"2025","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T19:07:22Z","timestamp":1763665642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825009630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":22,"alternative-id":["S0045206825009630"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109083","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and activity evaluation of selective CDK9 inhibitors containing indazole fragments","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109083"}}